Objective Inflammation and repair responses may be involved in atherosclerosis in rheumatoid arthritis (RA), although ...

An advisory committee will meet next week to review the information and make recommendations for the upcoming fall season. Charlie Kirk shooting suspect Tyler Robinson arrested, widow vows to fight ...

A pharmacy advertises COVID -19 testing and a vaccine on September 04, 2025 in the Brooklyn borough of New York City. Spencer Platt/Getty Images/AFP(Getty Images via AFP) Federal health officials are ...

LOS ANGELES - Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company with a market capitalization of $28 million, announced Wednesday that initial Phase 1 data for its ...

The INFORM real-world evidence study shows impact of semaglutide on reducing ‘food noise’, and the STEP UP clinical trial highlights semaglutide’s effect on control of eating and body composition ...

WATERTOWN, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, ...

1545 ET – Demand for Treasurys come back and yields fall as this week’s batch of labor data starts with a bit of a whimper. July JOLTS report shows a decline in job openings. August ADP data due ...

A popular Chinese financial data provider has halted releasing figures tracking local bond flows, according to some of the firm’s clients, as a rally in the country’s stock market fuels a selloff in ...

WINNIPEG, Manitoba, Sept. 04, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that Interim Chief Executive Officer, Dr. Robert Huizinga, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Nucana ( (NCNA)) just unveiled an ...

Presentation to highlight preclinical pharmacokinetic and safety data supporting once-daily usage of Corsair’s TRX-248 Transdermal System, now in a Phase 1 clinical study Corsair Pharma, Inc., a ...